Zobrazeno 1 - 10
of 60
pro vyhledávání: '"E. P. Trifonova"'
Autor:
S. G. Zakharov, T. A. Mitina, A. V. Zakharova, O. P. Madzyara, I. N. Kontievskii, R. V. Vardanyan, E. V. Kataeva, Yu. B. Chernykh, L. L. Vysotskaya, L. V. Ivanitskiy, Yu. Yu. Chuksina, O. R. Zhuravlev, N. V. Gorgun, Z. M. Kharasova, E. V. Trifonova, K. A. Belousov, Z. R. Tekeeva
Publikováno v:
Онкогематология, Vol 19, Iss 2, Pp 109-117 (2024)
Immune thrombocytopenia (ITP) is an autoimmune disease characterized by increased platelet destruction and decreased platelet production. The formation of antibodies to platelet and megakaryocyte glycoproteins plays a major role in the pathophysiolog
Externí odkaz:
https://doaj.org/article/30d95f9a80694e7ca526cd07cc2bf0e3
Autor:
G. S. Golosnaya, T. N. Belousova, M. Yu. Novikov, N. Yu. Knyazeva, D. Yu. Podkopaev, E. G. Trifonova, A. I. Makulova, Ya. Ya. Ginen, Z. A. Kozheurova, D. A. Kholichev, D. A. Politov, P. V. Baranova, N. A. Ermolenko, O. N. Krasnorutskaya, E. Ya. Kaledina, G. P. Tukabaev, A. V. Ogurtsov, K. A. Seleznev
Publikováno v:
Русский журнал детской неврологии, Vol 17, Iss 3, Pp 72-78 (2022)
Inherited metabolic disorders have a specific place among cases of sudden deterioration of the newborn’s condition. Therapies have been developed for some of these disorders. Accurate verification of the diagnosis is extremely important for choosin
Externí odkaz:
https://doaj.org/article/92c861fb959a4e0ab71105b12d2999cb
Autor:
A. V. Averyanov, T. V. Klypa, O. I. Balionis, M. V. Bychinin, A. V. Cherniak, A. V. Troitskiy, E. V. Trifonova
Publikováno v:
Медицинский совет, Vol 0, Iss 17, Pp 75-80 (2020)
The article presents a comparative retrospective analysis of clinical, laboratory data and outcomes in 39 patients with severe COVID-19 complicated by acute respiratory distress syndrome, who received high-flow oxygen therapy. Of which, 19 patients a
Externí odkaz:
https://doaj.org/article/d5d063840d8f42459f526909cd3bc67a
Autor:
K. A. Belousov, T. A. Mitina, Yu. Yu. Chuksina, A. K. Golenkov, E. V. Kataeva, E. V. Trifonova, Yu. B. Chernykh, L. L. Vysotskaya, S. G. Zakharov, E. F. Klinushkina, A. N. Mitin
Publikováno v:
Онкогематология, Vol 14, Iss 1, Pp 14-19 (2019)
Objective: to study the efficacy and safety of the antitumor RVP program (lenalidomide, bortezomib, prednisone) as a first-line therapy in patients with multiple myeloma (MM). Materials and methods. A prospective study involved 39 patients with MM (1
Externí odkaz:
https://doaj.org/article/9d44a6473ca940b5939c7131d1ff3f5b
Publikováno v:
Вавиловский журнал генетики и селекции, Vol 22, Iss 8, Pp 987-991 (2019)
Disease resistance is an important characteristic for each variety of potato, and the search for pathogen resistance markers is one of the primary tasks of plant breeding. Higher plants possess a wide spectrum of enzymes catalyzing the hydrolysis of
Externí odkaz:
https://doaj.org/article/ae60360a154442f4b5a319bf921740c5
Autor:
S. G. Zakharov, A. K. Golenkov, V. A. Misyurin, E. V. Kataeva, M. A. Baryshnikova, Yu. Yu. Chuksina, T. A. Mitina, E. V. Trifonova, L. L. Vysotskaya, Yu. B. Chernykh, E. F. Klinushkina, K. A. Belousov, Yu. P. Finashutina, A. V. Misyurin
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 46, Iss 8, Pp 734-741 (2018)
Background: We have previously shown that the FAS, TNFR2, TRAIL, DR3, DR4/5 gene expression in patients with newly diagnosed chronic lymphoblastic leukemia (CLL) correlates with clinical manifestations of the disease: they are minimal in patients wit
Externí odkaz:
https://doaj.org/article/5700002fb2d745459e510326b80d8937
Publikováno v:
Вавиловский журнал генетики и селекции, Vol 20, Iss 6, Pp 959-967 (2017)
Autism spectrum disorders are a separate group of defects with a very high genetic component. Genetic screening has identified hundreds of mutations and other genetic variations associated with autism, and bioinformatic analysis of signaling pathways
Externí odkaz:
https://doaj.org/article/5c885f32cc5f40a3beb5138d95e22e15
Autor:
Yu. B. Chernykh, A. K. Golenkov, S. S. Shushanov, T. A. Kravtsova, E. Yu. Rybalkina, A. F. Karamysheva, T. A. Mitina, E. V. Trifonova, E. V. Kataeva, L. L. Vysotskaya, A. A. Stavrovskaya
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 44, Iss 5, Pp 624-630 (2017)
Background: Implementation of a proteasome inhibitor bortezomib into treatment of multiple myeloma has helped to improve survival of patients with this malignancy that is characterized by continuous relapsing course as a clinical manifestation of mul
Externí odkaz:
https://doaj.org/article/94caa4122f9e4aa3848952bfd3104a3a
Autor:
T. A. Мitina, A. K. Golenkov, A. Yu. Baryshnikov, A. V. Karaulov, E. V. Trifonova, Yu. B. Chernykh, E. V. Katayeva, T. D. Lutskaya, L. L. Vysotskaya, G. A. Dudina, S. G. Zacharov, A. M. Fomin, N. V. Lyubimova, I. N. Kogarko
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 0, Iss 29, Pp 33-37 (2016)
Efficiency of the multiple myeloma treatment with chemotherapy including bortezomib was assessed based on determination of the level of immunoglobulin free light chains in blood serum. The method enables estimation of changes in kinetic parameters of
Externí odkaz:
https://doaj.org/article/05d3dfcce4404fb0a35c81461490811c
Autor:
L. L. Vysotskaya, A. K. Golenkov, E. V. Trifonova, T. A. Mitina, E. V. Kataeva, Yu. B. Chernykh
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 0, Iss 41, Pp 60-65 (2016)
Aim: To assess long-term efficacy of firstand second-line tyrosine kinase inhibitors in non-selected patients with chronic myeloid leukemia in a real-life clinical setting.Materials and methods: The assessment is based on long-term results of a prosp
Externí odkaz:
https://doaj.org/article/2bd96839a42b4e6b8f82cf3137b88b80